FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase.
Plasma levels of FGF23 are increased in patients with chronic kidney disease. Beside its role in phosphate homeostasis, iron deficiency and anemia are associated with increased FGF23 plasma levels. Recently, FGF23 plasma levels were shown to be increased in mice after treatment with hypoxia inducibl...
Main Authors: | Ingo Flamme, Peter Ellinghaus, Diana Urrego, Thilo Krüger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5658123?pdf=render |
Similar Items
-
Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01) -
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
by: Xiaofan Hu, et al.
Published: (2020-12-01) -
Inhibition studies on hypoxia-inducible factor (HIF) hydroxylases
by: Chan, Mun Chiang
Published: (2014) -
Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1α are Associated with Endometrial Cancer Aggressiveness
by: Zhu C, et al.
Published: (2019-11-01) -
Studies on the inhibition of human Hypoxia Inducible Factor (HIF) hydroxylases
by: Yeoh, Kar Kheng
Published: (2012)